Cassidy had backed every nominee who came before his committee
Republican Sen. Bill Cassidy, a Louisiana doctor who chairs the Senate health committee, said he remained undecided ahead of a critical vote scheduled for Wednesday. Cassidy had repeatedly tried to win commitments on upholding vaccine standards, including from Health Secretary Robert F. Kennedy Jr., by threatening to withhold his vote. He ultimately voted in favor of each nominee that came before his committee.
Sen. Susan Collins of Maine and other Republicans raised concerns about Overton’s approach to flavored e-cigarettes. The FDA recently authorized its first fruit-flavored e-cigarettes for adult smokers. Under previous administrations, including Trump’s first, the agency had opposed vaping flavors that could attract teens and children.
To win confirmation, Overton needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee. Democrats hold 11 seats. Without committee support, Overton faced little chance of winning a full Senate vote on the chamber floor.
Overton had faced bipartisan questions in the Senate about whether she would break from Trump, particularly over his unsupported claims about the dangers of childhood vaccines. At a September hearing, Cassidy pressed her about her scientific independence and willingness to push back against Trump and Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic. Cassidy had previously called Overton’s support for Trump’s plan to break up combination vaccines — including the measles, mumps and rubella shot — “almost disqualifying.”
With only a matter of weeks left in his term, Cassidy faced little downside in opposing the latest FDA nominee. He lost a primary race in June to run for a third term.
The White House said Tuesday that it had pulled Overton’s nomination amid growing indications she lacked the votes needed to win Senate confirmation. It was not immediately clear when the White House might put forward another nominee. Republicans had been racing to confirm Trump’s nominees before handing over power to Senate Democrats in January.
Opposition to Overton’s nomination also came from influential figures in the Make America Healthy Again movement, who blamed Overton and other White House officials for sidelining some of Health Secretary Robert F. Kennedy Jr.’s top health goals.
Earlier this month, Calley Means told Joe Rogan that White House aides, including Overton, worked within the administration to advance a Supreme Court decision blocking thousands of lawsuits over the weedkiller glyphosate. Means said that policy and other key decisions were carried out at the behest of industry lobbyists. “There is a very concentrated group in the Trump administration that are antagonistic to what people voted for,” Means said.
Trump had pulled back several other health nominations. His first nominee for the Centers for Disease Control and Prevention, Dr. David Weldon, was replaced because it was unclear he had enough Republican support to be confirmed. Two of Trump’s surgeon general nominees, including Dr. Casey Means — Calley Means’ sister — were pulled after facing pushback from Senate Republicans.
Overton is a physician and White House domestic policy adviser who spent most of her professional career working directly for Trump or for conservative groups aligned with his agenda. Her August nomination was seen as an effort to steady the FDA after a year marked by scientific disputes, leadership changes and media stories detailing low morale and internal dysfunction under Trump’s first FDA commissioner, Dr. Marty Makary.
The FDA has lost about 20% of its employees to layoffs, buyouts, retirements or resignations since Trump took office. The agency was being led on an acting basis by Kyle Diamantas, an attorney and friend of Donald Trump Jr. Trump elevated Diamantas to the post after he had served as the agency’s top food official.